Related Experiment Video
Updated: May 12, 2025

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation
Published on: September 6, 2024
Cell Death Modalities in Therapy of Melanoma
Meng Wang1, Jia-Hui Zhao1, Ming-Xuan Tang1
1Department of Human Anatomy, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Abstract:
Melanoma, one of the most lethal cancers, demands urgent and effective treatment strategies. However, a successful therapeutic approach requires a precise understanding of the mechanisms underlying melanoma initiation and progression. This review provides an overview of melanoma pathogenesis, identifies current pathogenic factors contributing to mortality, and explores targeted therapy and checkpoint inhibitor therapy. Furthermore, we examine melanoma classification and corresponding therapies, along with advancements in various cell death mechanisms for melanoma treatment. We also discuss the current treatment status along with some drawbacks encountered during research stages such as resistance and metastasis.
Insights
This review details melanoma pathogenesis, covering key factors, targeted therapies, and emerging cell death strategies. It highlights current treatments and challenges like resistance and metastasis in melanoma research.
Area of Science:
- Oncology
- Cancer Biology
- Dermatology
Background:
- Melanoma is a highly lethal skin cancer requiring effective treatments.
- Understanding melanoma initiation and progression is crucial for therapeutic success.
Purpose of the Study:
- To review melanoma pathogenesis and identify mortality-contributing factors.
- To explore targeted therapy, checkpoint inhibitor therapy, and cell death mechanisms in melanoma treatment.
- To discuss current melanoma treatment status and research challenges.
Main Methods:
- Literature review of melanoma pathogenesis.
- Analysis of pathogenic factors and their contribution to mortality.
- Examination of targeted therapy, immunotherapy, and cell death mechanisms.
- Discussion of melanoma classification and treatment strategies.
Main Results:
- Identified key pathogenic factors driving melanoma mortality.
- Reviewed advancements in targeted and checkpoint inhibitor therapies.
- Explored novel cell death mechanisms for therapeutic intervention.
- Highlighted current treatment efficacy and limitations.
Conclusions:
- A comprehensive understanding of melanoma pathogenesis is essential for developing effective treatments.
- Targeted therapies and immunotherapies show promise but face challenges.
- Further research into cell death mechanisms and overcoming resistance/metastasis is critical for improving melanoma patient outcomes.
Related Concept Videos
Tumor Immunotherapy
The Intrinsic Apoptotic Pathway
Targeted Cancer Therapies
There are several types of targeted therapies against...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

